Stibenyl

Stibenyl may be available in the countries listed below.

Ingredient matches for Stibenyl

Ramipril

Ramipril is reported as an ingredient of Stibenyl in the following countries:

• Greece

International Drug Name Search

Botulinum Toxin Type A

Pronunciation: OH-na-BOT-ue-li-num-TOX-in-A
Generic Name: OnabotulinumtoxinA
Brand Name: Botox Cosmetic

Botulinum Toxin Type A may spread from the injection site to other areas of the body, causing symptoms of a serious condition called botulism. These symptoms may occur hours to weeks after you receive Botulinum Toxin Type A. Symptoms may include loss of strength; muscle weakness; double or blurred vision; drooping eyelids; hoarseness; change or loss of voice; loss of bladder control; or trouble speaking, breathing, or swallowing. The risk may be greater in children being treated for spasticity (muscle spasms), but these symptoms may also occur in adults. Botulinum Toxin Type A is not approved for use in children. Contact your doctor immediately if these symptoms occur.

Severe and sometimes fatal breathing or swallowing problems have been reported. The risk may be greater in patients who already have breathing or swallowing problems. Tell your doctor if you have or are at risk of developing breathing or swallowing problems.

Botulinum Toxin Type A is used for:

Temporarily improving the appearance of moderate to severe lines between the eyebrows in patients 65 years old or younger. It may also be used for other conditions as determined by your doctor.

Botulinum Toxin Type A is a neurotoxin. It works by blocking nerve impulses to the muscles or sweat glands, temporarily paralyzing the muscle or gland.

Do NOT use Botulinum Toxin Type A if:

• you are allergic to any ingredient in Botulinum Toxin Type A or another botulinum product


• you have an infection at the injection site


• you are pregnant

Contact your doctor or health care provider right away if any of these apply to you.

Before using Botulinum Toxin Type A:

Some medical conditions may interact with Botulinum Toxin Type A. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have nerve problems or disease (eg, amyotrophic lateral sclerosis, motor neuropathy), muscle problems or disease (eg, Lambert-Eaton syndrome, myasthenia gravis), bleeding disorders, seizures, or severe weakness or wasting of the muscles at the injection site (eg, trouble raising your eyebrows, drooping eyelids)


• if you have a history of heart problems (eg, irregular heartbeat, a recent heart attack), swallowing or breathing problems (eg, asthma), or eye problems (eg, glaucoma, drooping eyelid)


• if you have a skin infection; or inflammation, scarring, or other skin disorders at the injection site


• if you plan to have surgery, especially surgery on your face, or if you have received Botulinum Toxin Type A or any other botulinum toxin within the past 4 months


• if you have weakness in your forehead muscles, have had any change in the way your face normally looks, or you have had surgery on your face


• if you are taking an allergy or cold medicine

Some MEDICINES MAY INTERACT with Botulinum Toxin Type A. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Aminoglycoside antibiotics (eg, gentamicin), anticholinesterase medicines (eg, neostigmine), lincosamides (eg, clindamycin), magnesium, muscle relaxants (eg, cyclobenzaprine), neuromuscular blockers (eg, atracurium), polymyxin, quinidine, or sleep medicines (eg, zolpidem) because they may increase the risk of Botulinum Toxin Type A's side effects


• Anticoagulants (eg, warfarin) because the risk of bleeding at the injection site may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Botulinum Toxin Type A may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Botulinum Toxin Type A:

Use Botulinum Toxin Type A as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Botulinum Toxin Type A comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Botulinum Toxin Type A refilled.


• Botulinum Toxin Type A is usually given as an injection at your doctor's office, hospital, or clinic.


• If you miss a dose of Botulinum Toxin Type A, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Botulinum Toxin Type A.

Important safety information:

• Botulinum Toxin Type A may cause dizziness, drowsiness, loss of strength, weakness, blurred vision, or drooping eyelids. These effects may be worse if you take it with alcohol or certain medicines. Use Botulinum Toxin Type A with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do NOT use more than the recommended dose or use Botulinum Toxin Type A more often than every 3 months without checking with your doctor.


• Tell your doctor or dentist that you take Botulinum Toxin Type A before you receive any medical or dental care, emergency care, or surgery.


• Do not switch brands of Botulinum Toxin Type A. Contact your doctor if you have any questions.


• Botulinum Toxin Type A contains albumin, which comes from human blood. There is a very rare risk of getting a viral disease or a central nervous system disease called Creutzfeldt-Jakob disease from products with albumin. No cases of these problems have been found in patients who have used Botulinum Toxin Type A.


• Botulinum Toxin Type A should not be used in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Do not use Botulinum Toxin Type A if you are pregnant. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Botulinum Toxin Type A while you are pregnant. It is not known if Botulinum Toxin Type A is found in breast milk. If you are or will be breast-feeding while you use Botulinum Toxin Type A, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Botulinum Toxin Type A:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Anxiety; back pain; dizziness; drowsiness; dry mouth; dry or irritated eyes; facial pain; flu-like symptoms; headache; inability to focus eyes; increased cough; indigestion; nausea; neck pain; pain, redness, swelling, or tenderness at the injection site; runny nose; sensitivity to light; stiff or weak muscles at or near the injection site; sweating.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bleeding at the injection site; chest pain; difficulty swallowing or breathing; double or blurred vision or other vision changes; drooping of the upper eyelid; eyelid swelling; fainting; fever, chills, or persistent sore throat; irregular heartbeat; loss of bladder control; loss of strength; paralysis; seizures; severe or persistent muscle weakness or dizziness; shortness of breath; speech changes or problems.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Botulinum Toxin Type A side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include paralysis; severe muscle weakness; trouble swallowing; weak or shallow breathing.

Proper storage of Botulinum Toxin Type A:

Botulinum Toxin Type A is usually handled and stored by a health care provider. If you are using Botulinum Toxin Type A at home, store Botulinum Toxin Type A as directed by your pharmacist or health care provider. Keep Botulinum Toxin Type A out of the reach of children and away from pets.

General information:

• If you have any questions about Botulinum Toxin Type A, please talk with your doctor, pharmacist, or other health care provider.


• Botulinum Toxin Type A is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Botulinum Toxin Type A. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Botulinum Toxin Type A resources

• Botulinum Toxin Type A Side Effects (in more detail)
• Botulinum Toxin Type A Use in Pregnancy & Breastfeeding
• Botulinum Toxin Type A Drug Interactions
• Botulinum Toxin Type A Support Group
• 18 Reviews for Botulinum Toxin Type A - Add your own review/rating

Compare Botulinum Toxin Type A with other medications

• Blepharospasm
• Cervical Dystonia
• Dystonia
• Facial Wrinkles
• Hyperhidrosis
• Migraine Prevention
• Overactive Bladder
• Spasticity
• Strabismus
• Upper Limb Spasticity
• Urinary Incontinence

Paracetamolo

Paracetamolo may be available in the countries listed below.

Ingredient matches for Paracetamolo

Paracetamol

Paracetamolo (DCIT) is also known as Paracetamol (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Latanoprost Gerolymatos

Latanoprost Gerolymatos may be available in the countries listed below.

Ingredient matches for Latanoprost Gerolymatos

Latanoprost

Latanoprost is reported as an ingredient of Latanoprost Gerolymatos in the following countries:

• Greece

International Drug Name Search

Gentalol

Gentalol may be available in the countries listed below.

Ingredient matches for Gentalol

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentalol in the following countries:

• Japan

International Drug Name Search

Zyrox

Zyrox may be available in the countries listed below.

Ingredient matches for Zyrox

Roxithromycin

Roxithromycin is reported as an ingredient of Zyrox in the following countries:

• Myanmar

International Drug Name Search

Laboxantryl

Laboxantryl may be available in the countries listed below.

Ingredient matches for Laboxantryl

Mesalazine

Mesalazine is reported as an ingredient of Laboxantryl in the following countries:

• Greece

International Drug Name Search

Vit Aid Vitamin A

Vit Aid Vitamin A may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vit Aid Vitamin A

Retinol

Retinol is reported as an ingredient of Vit Aid Vitamin A in the following countries:

• South Africa

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Vit Aid Vitamin A in the following countries:

• South Africa

International Drug Name Search

Zanicor

Zanicor may be available in the countries listed below.

Ingredient matches for Zanicor

Lercanidipine

Lercanidipine hydrochloride (a derivative of Lercanidipine) is reported as an ingredient of Zanicor in the following countries:

• Portugal

International Drug Name Search

Zoomec

Zoomec may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Zoomec

Abamectin

Abamectin is reported as an ingredient of Zoomec in the following countries:

• Australia

International Drug Name Search

Thymoxamine

Thymoxamine may be available in the countries listed below.

Ingredient matches for Thymoxamine

Moxisylyte

Thymoxamine (BAN) is also known as Moxisylyte (Rec.INN)

International Drug Name Search

Glossary

BAN	British Approved Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Midazolam B. Braun

Midazolam B. Braun may be available in the countries listed below.

Ingredient matches for Midazolam B. Braun

Midazolam

Midazolam is reported as an ingredient of Midazolam B. Braun in the following countries:

• Greece


• Luxembourg

Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Midazolam B. Braun in the following countries:

• Belgium


• Estonia


• Latvia


• Spain


• Switzerland

International Drug Name Search

Robinul Forte

Generic Name: glycopyrrolate (Oral route)

glye-koe-PIR-oh-late

Commonly used brand name(s)

In the U.S.

• Cuvposa


• Robinul


• Robinul Forte

Available Dosage Forms:

• Tablet


• Solution

Therapeutic Class: Gastrointestinal Agent

Pharmacologic Class: Antimuscarinic

Uses For Robinul Forte

Glycopyrrolate is used to treat peptic ulcers in adults. It is also used to treat chronic, severe drooling caused by certain neurologic disorders (e.g., cerebral palsy) in children 3 to 16 years of age. This medicine is an anticholinergic.

Glycopyrrolate may also be used for other conditions as determined by your doctor.

This medicine is available only with your doctor's prescription.

Before Using Robinul Forte

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of glycopyrrolate in children 3 to 16 years of age. However, safety and efficacy have not been established in children younger than 3 years of age.

Geriatric

No information is available on whether the risk of glycopyrrolate-induced adverse effects are increased in the elderly; however, it should be used with caution because elderly patients are more likely to have age related liver disease, kidney disease, heart disease, or prostate problems. This may require a dosage adjustment or careful monitoring in elderly patients receiving glycopyrrolate.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Potassium

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Colostomy (bowel surgical procedure) or


• Congestive heart failure or


• Heart disease or


• Heart rhythm problems or


• Hiatal hernia with gastroesophageal reflux disease (GERD) or


• Hypertension (high blood pressure) or


• Hyperthyroidism (overactive thyroid) or


• Ileostomy (bowel surgical procedure) or


• Liver disease or


• Nerve problems (e.g., neuropathy) or


• Prostatic hypertrophy (enlarged prostate) or


• Ulcerative colitis—Use with caution. May make these conditions worse.

• Glaucoma or


• Myasthenia gravis (severe muscle weakness) or


• Obstructive uropathy (urinary blockage due to enlarged prostate or other condition) or


• Paralytic ileus (bowel blockage) or


• Stomach or intestinal problems (e.g., ulcerative colitis, toxic megacolon, bowel obstruction), severe or


• Trouble urinating—Should not be used in patients with these conditions.

• Kidney disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of glycopyrrolate

This section provides information on the proper use of a number of products that contain glycopyrrolate. It may not be specific to Robinul Forte. Please read with care.

Your doctor will tell you how much of this medicine to use and how often. The dose may need to be changed several times in order to find out what works best for you or your child. Do not use more medicine or use it more often than your doctor tells you to.

This medicine comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.

Measure the oral liquid with a marked measuring spoon, oral syringe, or medicine cup. The average household teaspoon may not hold the right amount of liquid.

You should take this medicine at least one hour before or two hours after meals.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For oral dosage form (solution):
  
  • For severe drooling:
    
    • Children 3 to 16 years of age—Dose is based on body weight and must be determined by your child's doctor. The dose is 0.02 milligram (mg) per kilogram (kg) of body weight three times a day. Your child's doctor may increase your child's dose as needed. However, the dose is usually not more than 1.5 to 3 mg per dose.
    
    
    • Children younger than 3 years of age—Use and dose must be determined by your child's doctor.
    
    
  
  


• For oral dosage form (tablet):
  
  • For peptic ulcers:
    
    • Adults and children 12 years of age and older—The initial dose is 1 mg three times daily. Your doctor will adjust the dose as needed. However, the dose is usually not more than 8 mg per day.
    
    
    • Children younger than 12 years of age—Use is not recommended.
    
    
  
  

Missed Dose

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using Robinul Forte

It is very important that your doctor or your child's doctor check your progress at regular visits. This will allow your doctor to make sure that this medicine is working properly and to check for unwanted effects.

You should not take potassium chloride tablets or other potassium supplements (in tablet or capsule forms) while is using this medicine. Using these medicines together may cause delayed movement of the potassium supplement through the esophagus and stomach.

This medicine may cause constipation or diarrhea. Constipation or diarrhea can be an early symptom of a serious bowel problem. Stop using this medicine and check with your doctor if you or your child has constipation, diarrhea, abdominal or stomach distention (swelling), pain, nausea, or vomiting.

Stop using this medicine and check with your doctor right away if your child is unable to urinate, has dry diapers or undergarments, or has the following symptoms while using this medicine: crying, irritability, decrease in the frequency of urine, or difficult or painful urination.

If you or your child develops a skin rash, hives, or any allergic reaction to this medicine, stop taking the medicine and check with your doctor as soon as possible.

This medicine may make you or your child sweat less, causing your body temperature to increase. Use extra care to avoid becoming overheated during exercise or hot weather while you are taking this medicine, since overheating may result in heat stroke.

This medicine may make you or your child drowsy or cause blurred vision. Avoid driving, using machines, or doing anything else that could be dangerous if you are not alert.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Robinul Forte Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

More common

• Body aches or pain


• chills


• constipation


• cough


• decrease in the frequency of urination


• decrease in urine volume


• difficulty in passing urine (dribbling)


• difficulty with breathing


• ear congestion


• feeling of warmth


• fever


• headache


• loss of voice


• nasal congestion


• painful urination


• redness of the face, neck, arms, and occasionally, upper chest


• runny nose


• sneezing


• sore throat


• unusual tiredness or weakness

Less common

• Abdominal or stomach discomfort or pain


• abdominal or stomach distension


• chest pain


• confusion


• convulsions


• dizziness


• dry heaves


• dry mouth


• fainting


• increase in heart rate


• lightheadedness


• pain or tenderness around the eyes and cheekbones


• rapid breathing


• shortness of breath or troubled breathing


• stuffy nose


• sunken eyes


• thirst


• tightness in the chest


• vomiting


• wheezing


• wrinkled skin

Get emergency help immediately if any of the following symptoms of overdose occur:

• low blood pressure


• muscle weakness


• trouble breathing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

• Altered mood


• anxiety


• attack, assault, or force


• bloated


• change in taste


• chapped lips


• crying


• dry skin


• dry tongue


• excess air or gas in the stomach or intestines


• full feeling


• hyperventilation


• irregular heartbeats


• irritability


• loss of taste


• moaning


• nervousness


• pain


• paleness of the skin


• passing gas


• rash


• restlessness


• shaking


• trouble with sleeping


• uncontrolled eye movements

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Robinul Forte side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Robinul Forte resources

• Robinul Forte Side Effects (in more detail)
• Robinul Forte Use in Pregnancy & Breastfeeding
• Drug Images
• Robinul Forte Drug Interactions
• Robinul Forte Support Group
• 0 Reviews for Robinul Forte - Add your own review/rating

• Robinul Forte MedFacts Consumer Leaflet (Wolters Kluwer)


• Glycopyrrolate Professional Patient Advice (Wolters Kluwer)


• Glycopyrrolate Monograph (AHFS DI)


• Glycopyrrolate MedFacts Consumer Leaflet (Wolters Kluwer)


• Cuvposa Prescribing Information (FDA)


• Cuvposa Consumer Overview


• Cuvposa Solution MedFacts Consumer Leaflet (Wolters Kluwer)


• Robinul Prescribing Information (FDA)

Compare Robinul Forte with other medications

• Anesthesia
• Peptic Ulcer

Otilonium Bromide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AB06

CAS registry number (Chemical Abstracts Service)

0026095-59-0

Chemical Formula

C29-H43-Br-N2-O4

Molecular Weight

563

Therapeutic Categories

Antispasmodic agent

Parasympatholytic agent

Chemical Name

Ethanaminium, N,N-diethyl-N-methyl-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-, bromide

Foreign Names

• Otilonii Bromidum (Latin)
• Otilonium bromid (German)
• Bromure d'Otilonium (French)
• Bromuro de otilonio (Spanish)

Generic Names

• Otilonio bromuro (OS: DCIT)
• Otilonium Bromide (OS: BAN)

Brand Names

• Doralin
  Menarini, Greece



• Lonium
  Apsen, Brazil



• Otilax
  Biospray, Greece



• Pasminox
  Beta, Argentina



• Spasen
  Firma, Italy



• Spasmoctyl
  Guidotti, Spain; Menarini, Argentina; Menarini, Costa Rica; Menarini, Dominican Republic; Menarini, Guatemala; Menarini, Honduras; Menarini, Nicaragua; Menarini, Panama; Menarini, El Salvador



• Spasmogen
  Menarini, Israel



• Spasmomen
  Berlin-Chemie, Bulgaria; Berlin-Chemie, China; Berlin-Chemie, Hungary; Berlin-Chemie, Romania; Biotoscana, Colombia; Biotoscana, Peru; Dexa Medica, Indonesia; I.E. Ulagay, Turkey; Menarini, United Arab Emirates; Menarini, Belgium; Menarini, Bahrain; Menarini, Cyprus; Menarini, Czech Republic; Menarini, Ecuador; Menarini, Egypt; Menarini, Hong Kong; Menarini, Israel; Menarini, Iraq; Menarini, Italy; Menarini, Jordan; Menarini, Kuwait; Menarini, Lebanon; Menarini, Lithuania; Menarini, Luxembourg; Menarini, Latvia; Menarini, Libya; Menarini, Morocco; Menarini, Malta; Menarini, Portugal; Menarini, Qatar; Menarini, Saudi Arabia; Menarini, Sudan; Menarini, Syria; Menarini, Tunisia; Menarini, Yemen

International Drug Name Search

Glossary

BAN	British Approved Name
DCIT	Denominazione Comune Italiana
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.